Somebody call Griffin and inform him that there ARE competitors of ValiMed, LOL.
"ASD's RxSpec system, launched in late 2004, shines a light on a drug, developing a "near-infrared chemical fingerprint," chief executive Dave Rzasa said, and compares it to a known library of such prints to make sure they match.
The device currently is used by high-output pharmacies, including the Veterans Administration's Consolidated Mail Outpatient Pharmacies. But the company is also developing smaller systems for use in individual drugstores."
______________________________________________________________
"We're unaware of a competitor that is offering a similar product," says Jim Griffin"
____________________________________________________________
What is it Mr. Griffin? You are supposed to know better, yet you seem not to know. Or, rather, want to give the impression of something that is false and misleading. |
